ConductScience.org, home

Paper16610047

Chemotherapy as a component of multimodal therapy for gastric carcinoma.

Kodera Y and 3 others. World J Gastroenterol, 2006. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Chemotherapy as a component of multimodal therapy for gastric carcinoma. Papers, record 16610047. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16610047

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapy as a component of multimodal therapy for gastric carcinoma.
PubMed
Journal
World J Gastroenterol
PubMed
Year
2006
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2023-11-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kodera YYasuhiro
2Fujiwara MMichitaka
3Koike MMasahiko
4Nakao AAkimasa

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Stomach NeoplasmsMajor topic
Chemotherapy, Adjuvant
Combined Modality Therapy
Humans

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112672044Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry.Int J Cancer2003https://conductscience.org/library/papers/12672044PubMed
215289487Chemotherapy sensitivity and resistance assays: a systematic review.J Clin Oncol2004https://conductscience.org/library/papers/15289487PubMed
38620402A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan.Cancer1995https://conductscience.org/library/papers/8620402PubMed
415718321Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.J Clin Oncol2005https://conductscience.org/library/papers/15718321PubMed
59404711The National Cancer Data Base report on gastric carcinoma.Cancer1997https://conductscience.org/library/papers/9404711PubMed
69591011Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.Surgery1998https://conductscience.org/library/papers/9591011PubMed
710089184Extended lymph-node dissection for gastric cancer.N Engl J Med1999https://conductscience.org/library/papers/10089184PubMed
815521189Molecular method to quantitatively detect micrometastases and its clinical significance in gastrointestinal malignancies.Adv Clin Chem2004https://conductscience.org/library/papers/15521189PubMed
98658219Surgery for gastric cancer: the American view.Semin Oncol1996https://conductscience.org/library/papers/8658219PubMed
1010077040Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.Ann Surg1999https://conductscience.org/library/papers/10077040PubMed
119552056Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study.J Clin Oncol1998https://conductscience.org/library/papers/9552056PubMed
1210917557Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden.Br J Cancer2000https://conductscience.org/library/papers/10917557PubMed
1314532985Quantitative molecular diagnosis of peritoneal lavage fluid for prediction of peritoneal recurrence in gastric cancer.Int J Oncol2003https://conductscience.org/library/papers/14532985PubMed
1410705010Paclitaxel and concurrent radiation for gastric cancer.Int J Radiat Oncol Biol Phys2000https://conductscience.org/library/papers/10705010PubMed
159915239Total gastrectomy with extended lymphadenectomy for "curable" stomach cancer: experience in a non-Japanese Asian center.J Am Coll Surg1999https://conductscience.org/library/papers/9915239PubMed
1610997811
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).
Ann Oncol2000https://conductscience.org/library/papers/10997811PubMed
1714662433Excisional surgery for cancer cure: therapy at a cost.Lancet Oncol2003https://conductscience.org/library/papers/14662433PubMed
1811923135Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment.Ann Surg Oncol2002https://conductscience.org/library/papers/11923135PubMed
1910577853Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer.J Clin Oncol1999https://conductscience.org/library/papers/10577853PubMed
20868069Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.World J Surg1977https://conductscience.org/library/papers/868069PubMed

See all 66 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
316960317-H-Pyrrolo[2,3-d]pyrimidine derivative acts as promising agent for gastric cancer treatment by inducing cell death.3 Biotech2019https://conductscience.org/library/papers/31696031PubMed
31545303Inhibition of Proliferation of SGC7901 and BGC823 Human Gastric Cancer Cells by Ursolic Acid Occurs Through a Caspase-Dependent Apoptotic Pathway.Med Sci Monit2019https://conductscience.org/library/papers/31545303PubMed
30569134Corilagin induces apoptosis, autophagy and ROS generation in gastric cancer cells in vitro.Int J Mol Med2019https://conductscience.org/library/papers/30569134PubMed
23673986Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts.Med Oncol2013https://conductscience.org/library/papers/23673986PubMed
22674056Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer.Cancer Immunol Immunother2012https://conductscience.org/library/papers/22674056PubMed
21792349Long-term survival of resected advanced gastric cancer with hepatic and pancreatic invasion.Case Rep Gastroenterol2011https://conductscience.org/library/papers/21792349PubMed
21160641Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma.World J Gastrointest Oncol2010https://conductscience.org/library/papers/21160641PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16610047

GET https://conductscience.org/api/papers/v1/16610047/references?page=2